Connecting the Oncology Community in Oklahoma

OSCO serves as the hub for oncology-related news and advances in Oklahoma. Our organization is made up of clinics and healthcare professionals working together to safeguard the rights of patients and to maintain high medical and ethical standards in the industry.

News

KEYTRUDA® approved by the FDA for the treatment of patients with cSCC that is n

Merck is pleased to announce that KEYTRUDA® (pembrolizumab) injection 100 mg has been approved by the FDA for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC) that is not curable by surgery or radiation. • PD-L1 diagnostic testing is not required prior to initiating treatment with KEYTRUDA in these patients. PD-L1=programmed death ligand […]

Read More...

CMS modifies Medicare Medically Unlikely Edit (MUE) Value for KEYTRUDA®

Merck has informed OSCO that the Medicare Medically Unlikely Edit (MUE) value has been modified for KEYTRUDA® (pembrolizumab). The MUE for KEYTRUDA was modified effective July 1, 2020. A list of quarterly Procedure-to-Procedure and MUE version update changes from CMS can be found here. Payer coding and coverage requirements may vary or change over time, so it […]

Read More...

KEYTRUDA® Approved by FDA for Additional Indication.

Merck has announced that the FDA has approved KEYTRUDA® (pembrolizumab) for the first-line treatment of patients with unresectable or metastatic MSI-H or dMMR colorectal cancer (CRC). MSI-H/dMMR testing is required prior to initiating treatment with KEYTRUDA in these patients. For the MSI-H/dMMR indication, select patients for treatment with KEYTRUDA as a single agent based on MSI-H/dMMR status in […]

Read More...

Upcoming Events

Due to ongoing public health concerns regarding COVID-19 and the concern for the safety and well-being of our members and supporters, OSCO is postponing all in-person events until 2021.  Please watch for information about our future events.

Learn More »

Become a Sponsor

Your company can sponsor OSCO and the work we do by becoming a corporate member today! For more information or to sign up, contact Kathy Musson, OSCO Executive Director at [email protected] or by phone at 405-850-8334.

See More »

Who We Are

Who We Are

The Oklahoma Society of Clinical Oncology (OSCO) is Oklahoma’s only professional organization that represents all those in oncology. Our membership works to advance the sciences of hematology and oncology and its sub-specialties, and to improve services to the public by studying the socio-economic aspects of the practice of our members.

Learn More »